Peter Blume-jensen
Genetics & Molecular Biology
Veritas Genetics
China
Biography
Peter Blume-Jensen, MD, PhD Scientific leader in personalized oncology, targeted oncology therapeutics, and biomarker research. Currently CSO Xtuit. Former executive with Metamark Genetics, Daiichi Sankyo, Merck and Serono.
Research Interest
Genetics & Oncology